All articles tagged with #lone star tick
Mass General Brigham’s Martha’s Vineyard Hospital will enroll up to 300 island residents who have been bitten by a lone-star tick in a two-year study to understand which people develop alpha-gal syndrome, what risk factors exist, and how the immune system changes over time, with hopes of informing diagnosis, prevention and potential treatments.
Bourbon virus, first identified in 2014 in Bourbon County, Kansas, is a rare tick-borne illness spread by lone star ticks. Cases have been limited but include a 2024 fatal Kansas case and renewed attention after New York’s first confirmed case; there is no commercial test, vaccine, or specific treatment, so prevention focuses on avoiding tick bites and doctors treat symptoms as needed.
Researchers in New York confirmed the first Bourbon virus case in the state (Long Island), a rare tick-borne illness with no vaccine or specific treatment; experts warn more infections may go undiagnosed and call for expanded surveillance, better testing, and reinforced tick-prevention measures.
The first Bourbon virus case in New York (Long Island) has been confirmed in a severely ill patient. As a rare tick-borne illness with no vaccine or specific treatment, Bourbon virus may be underdiagnosed, leading researchers to call for expanded surveillance and heightened clinician awareness to improve detection and tracking.
A Long Island man’s 2021 tick bite led to the first identified Bourbon virus case in New York, diagnosed in 2026 after years of debilitating symptoms and an initial misdiagnosis as Lyme disease. Bourbon virus is rare and untreatable, with limited testing and only a few confirmed cases and deaths historically. There is no vaccine or specific cure; patients receive supportive care, and prevention hinges on avoiding tick bites and tick-proofing outdoor spaces. The case underscores that Bourbon virus may be underdiagnosed in regions with dense Lone Star tick populations.
New research confirms Bourbon virus—an ultra-rare, tick-borne pathogen with no cure—exists in New York. In a study of 107 patients with suspected tickborne illness, investigators found one confirmed case in a Long Island man who was hospitalized but recovered; serology showed two people with neutralizing antibodies and a third with a rising antibody titer suggesting a recent infection, indicating the virus may be underdiagnosed in the region as lone-star ticks expand northward. The findings underscore the need for expanded viral surveillance, better clinical testing, and vector management, alongside standard tick-avoidance precautions since there is no specific treatment or vaccine.
A Suffolk County man is New York's first confirmed Bourbon virus case, infected in 2021 by lone star ticks. He developed fever, rash and severe headaches after an initial Lyme-era antibiotic treatment, and there is no vaccine, routine test, or specific treatment for Bourbon virus. He recovered after five days in hospital; the case underscores that Bourbon virus is rare but may be underdiagnosed in the Northeast as lone star ticks and deer expand their range.
A Stony Brook–led study confirms Bourbon virus cases in New York linked to lone star ticks, with antibodies detected in some patients. First identified in 2014 and associated with severe illness, the virus has no commercial test, vaccine, or targeted treatment, making diagnosis difficult and often leading to misattribution (e.g., Lyme disease). The findings come as tick bites and related ER visits rise nationwide, underscoring the need for better diagnostics and awareness of tick-borne threats.
Wisconsin is seeing a northward rise in lone star ticks, the main carrier of alpha-gal syndrome, with 33 ticks identified so far in 2026—more than five times 2025—while overall tick activity is high and the climate may be expanding their range. Alpha-gal can trigger a red meat and dairy allergy, though not everyone develops symptoms; other ticks may also carry the allergy. A resident case illustrates life-changing impacts, and officials recommend prevention: protective clothing, repellents, permethrin-treated gear, and thorough tick checks.
Alpha-gal syndrome is a tick-bite–triggered allergy to a sugar in most mammal tissues, meaning that after a tick bite, eating meat (and some other animal products) can trigger symptoms like hives, nausea or more severe reactions, with onset often 2–6 hours later. The Lone Star Tick is a primary carrier in the U.S., though other ticks can cause it. There’s no cure; testing is increasingly available. Prevention focuses on avoiding tick bites via protective clothing, repellents, yard maintenance, and routine tick checks, and Michigan health officials warn the risk may grow as tick populations expand.
Vineyard epidemiologist Lea Hamner and clinician Aubrey Stimola Ryan attended the nation’s first Alpha-gal Syndrome conference in Raleigh to discuss Martha’s Vineyard’s rising tick-borne allergy, highlight an islandwide prevention-and-treatment effort (including a future tick clinic and deer-management), and note that while reporting, labeling, and national coordination will improve, a medical cure remains distant and prevention hinges on avoiding bites and using permethrin-treated clothing.
A CDC analysis of 3,000 blood samples from 10 states found about 24% of adults in five states with high lone star tick presence have antibodies to alpha-gal, indicating prior tick bites and exposure to the sugar molecule linked to alpha-gal syndrome—a lifelong red-meat allergy that can trigger reactions hours after eating meat. Experts caution that antibodies signal exposure, not a diagnosed condition, but rising tick spread and migration may increase future risk; prevalence estimates vary and not all cases are reported, underscoring the need for more research.
A CDC analysis of 3,000 adults across 10 states found about 24% in five states with high lone star tick activity have antibodies to alpha-gal, indicating prior tick bites and potential risk for alpha-gal syndrome (a red meat allergy). Antibodies show exposure, not disease, so not everyone will develop symptoms. The true prevalence is uncertain, and cases are not nationally notifiable; ticks and affected areas may expand as deer move and winters warm. Symptoms typically appear hours after eating red meat, and the condition is lifelong once developed.
Alpha-gal syndrome is a potentially life‑threatening meat allergy triggered by lone star tick bites, causing delayed reactions after eating mammal meats while seafood and poultry are safe. About 450,000 Americans are affected as the lone star tick’s range expands. The allergy results from antibodies to the alpha-gal sugar introduced by bites; diagnosis combines symptoms with a blood test, though tests can yield false positives. Management typically involves avoiding mammal meats (and sometimes dairy) and carrying an epinephrine injector. In 2024 the FDA approved Xolair to reduce severe reactions, with ongoing research into additional therapies; some patients may outgrow the condition after years, but avoiding new tick bites remains crucial.
Alpha-gal syndrome is a life-threatening meat allergy linked to tick bites, especially from the lone star tick, estimated to affect about 450,000 Americans. Symptoms typically appear hours after consuming mammal meat or dairy, and diagnosis relies on symptoms plus blood tests that can yield false positives. Management centers on avoiding beef, pork, and lamb, carrying an epinephrine injector, and, in 2024, FDA-approved Xolair to reduce severe reactions; some patients may outgrow the allergy over years, while researchers are exploring additional therapies and considerations like GalSafe pig meat and certain medical implants.